MICHAEL TOMETSKO: Open Payments
NPI 1902954605 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,121 in 150 payments from 28 companies in 2025. Trend: 2023 $333 · 2024 $3,654 · 2025 $10,121
Speaker / faculty: $7,050Food & beverage: $3,002Travel & lodging: $69
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 21 | $7,459 |
| ABBVIE INC. | 24 | $540 |
| Eisai Inc. | 21 | $400 |
| Vanda Pharmaceuticals Inc. | 9 | $222 |
| Lundbeck LLC | 11 | $184 |
| PFIZER INC. | 12 | $155 |
| Lilly USA, LLC | 6 | $151 |
| Genentech USA, Inc. | 5 | $113 |
| Biogen, Inc. | 5 | $106 |
| Amgen Inc. | 5 | $84 |
Products named: BRIUMVI, Leqembi, QULIPTA, PONVORY, UBRELVY, VYEPTI, AMYVID, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
